Stocktoria
CytomX Therapeutics, Inc. CTMX
CytomX Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| Point72 Asset Management, L.P. | 7,875,390 | $37.0M | 4.63% |
| CITADEL ADVISORS LLC | 5,899,193 | $27.7M | 3.47% |
| MILLENNIUM MANAGEMENT LLC | 3,660,190 | $17.2M | 2.15% |
| TWO SIGMA INVESTMENTS, LP | 2,710,156 | $12.7M | 1.59% |
| BlackRock Finance, Inc. | 1,139,029 | $1.4M | 0.67% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.